期刊文献+

抗EGFR单克隆抗体表面电荷不均一性的分析条件优化

Optimization of Conditions for Analysis of Surface Charge Heterogeneity of Anti-EGFR Monoclonal Antibody
原文传递
导出
摘要 优化离子交换色谱法分析抗表皮生长因子受体(Epidermal growth factor receptor,EGFR)单克隆抗体表面电荷不均一性的条件。考察了离子交换色谱法分析抗EGFR单克隆抗体表面电荷不均一的条件,包括色谱柱、流动相pH、梯度及柱温。离子交换色谱法分析表面电荷不均一性的最佳条件:TSK-gelCM-STAT离子交换色谱柱、流动相pH6.0、合适的起始梯度及梯度陡度有利于电荷不均一性各组分的分离,柱温为40℃。合适的分析条件能够使单克隆抗体表面电荷不均一性各组分在离子交换色谱柱上得到最佳分离及获得较高灵敏度。 The analytical conditions of surface charge heterogeneity of anti-EGFR(epidermal growth factor receptor,EGFR)monoclonal antibody were optimized by ion exchange chromatography.The conditions,including column type,pH of mobile phase,gradient and column temperature,of surface charge heterogeneity of anti-EGFR monoclonal antibody were investigated by ion exchange chromatography.The optimal conditions of surface charge heterogeneity of anti-EGFR monoclonal antibody by ion exchange chromatography were as follows: column of TSK-gel CM-STAT,pH of mobile phase at 6.0,column temperature of 40℃,appropriate start gradient and gradient availed the separation of each component of charge heterogeneity.The suit analytical conditions can make the surface charge heterogeneity of anti-EGFR monoclonal antibody obtain the optimal separation and relative high sensitivity on ion exchange chromatography.
出处 《光谱实验室》 CAS CSCD 2012年第2期789-792,共4页 Chinese Journal of Spectroscopy Laboratory
基金 河南省教育厅自然科学研究计划项目(2011B150041)
关键词 抗表皮生长因子受体单克隆抗体 离子交换色谱法 表面电荷不均一性 Anti-EGFR Monoclonal Antibody Ion Exchange Chromatography Surface Charge Heterogeneity
  • 相关文献

参考文献8

  • 1Vlasak J,Ionescu R.Heterogeneity of Monoclonal Antibodies Revealed by Charge-Sensitive Methods[J].Curr.Pharm.Biotechnol,2008,9(6):468-481.
  • 2Robinson N E,Robinson A B.Molecular Clocks:Deamidation of Asparaginyl and Glutaminyl Residues in Peptides and Proteins[M].Cave Junction,OR,USA:Althouse Press,2004.51-145.
  • 3Robinson N E,Robinson Z W,Robinson B R et al.Structure-Dependent Nonenzymatic Deamidation of Glutaminyl and AsparaginylPentapeptides[J].J.Pept.Res.,2004,63(5):426.
  • 4Jefferis R.Glycosylation of Recombinant Antibody Therapeutics[J].Biotechnology Progress,2005,21(1):11-16.
  • 5Han M,Guo A,Jochheim C et al.Analysis of Glycosylated Type II Interleukin-1 Receptor(IL-1R)by Imaged Capillary IsoelectricFocusing(i-cIEF)[J].Chromatographia,2007,66(11-12):969-976.
  • 6Douglass J V,Wallace A,Balland A.Saparation of Populations of Antibody Variants by Fine Tuning of Hydrophobic-InteractionChromatography Operating Conditions[J].Journals of Chromatography A,2008,1214(1-2):81-89.
  • 7Quan C,Alcala E,Petkovska I et al.A Study in Glycation of a Therapeutic Recombinant Humanized Monoclonal Antibody:Where Itis,How It Got There and How It Affects Charge-Based Behavior[J].Anal.Biochem.,2008,373(2):179-191.
  • 8Melmer M,Stangler T,Schiefmeier M et al.HILIC Analysis of Fluorescence-Labeled N-Glycans from RecombinantBiopharmaceuticals[J].Anal.Bioanal.Chem.,2010,398(2):905-914.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部